Home/ Supplements/ Omega 3/ Extend Wise

Extend Wise

product on market Capsule InfoWars Life Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Fish oil and Coenzyme Q10 have moderate research support for supporting cardiovascular and cognitive health. Garlic bulb extract is often used for its potential antimicrobial and heart-health properties. Overall, the evidence coverage for this specific combination of ingredients is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Extend Wise
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
60
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Fat
1 Gram(s) (2% DV)
750 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
100 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)

Other Ingredients

Bovine Gelatin Glycerin Beeswax purified Water Lecithin Annatto
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one softgel daily.

Warnings & Precautions

Contains: Fish (sardine, anchovy, mackerel). Soy.

Consult your physician before using this product if nursing, pregnant, or have a serious condition.

Formulation Notes

Fish oil + CoQ10 + garlic

Additional Information

Made in U.S.A.

Fresh The #1 health product line suggested by Alex Jones

Store at room temperature

Metadata

Product Details

UPC / SKU8 10083 030405 8
DSLD Entry Date2020-04-23
Product TypeOther Combinations
FormCapsule
DSLD ID218912
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.